When Health Minister Mark Butler rose in Question Time yesterday to highlight progress on access to blood cancer therapies, his intent was to demonstrate that the system is working, delivering access to cutting-edge treatments through the Pharmaceutical Benefits Scheme. Analyse the timelines.
If these can be presented as positives, then we really have become accustomed to terrible
March 26, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Sanofi volunteers confront homelessness at Vinnies CEO Sleepout
June 19, 2026 - - Latest News -
Infectious diseases across the lifespan are a hidden burden beyond the acute episode
June 19, 2026 - - Latest News -
Gilead rushes remdesivir to Uganda to support Ebola response
June 19, 2026 - - Latest News -
Rhapsido approved in Australia as first oral targeted option for chronic spontaneous urticaria
June 18, 2026 - - Latest News -
Is China's international benchmarking a bigger short-term risk to medicines access?
June 18, 2026 - - Latest News -
Life sciences leaders brace for class action wave as dispute risks multiply
June 18, 2026 - - Latest News -
Australia's life sciences sector welcomes new CGT concession but urges RDTI fixes
June 18, 2026 - - Latest News

